Guangzhou, China

Qihang Ding

This inventor holds 1 USPTO granted patent. Top assignee: Chinese Academy of Sciences. Active years: 2021.


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2021

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Qihang Ding: Innovator in Kinetic Hydrate Inhibitors

Introduction

Qihang Ding is a notable inventor based in Guangzhou, China. He has made significant contributions to the field of polymer chemistry, particularly in the development of kinetic hydrate inhibitors. His innovative work has led to advancements that are crucial for various industrial applications.

Latest Patents

Qihang Ding holds a patent for a "Vinylamide block copolymer kinetic hydrate inhibitor and preparation method and use thereof." This invention involves a vinylamide block copolymer that serves as a kinetic hydrate inhibitor. The preparation method utilizes reverse atom transfer radical polymerization under anaerobic conditions, employing vinylcaprolactam and acrylamide as monomers. The process results in a poly(vinylcaprolactam-acrylamide) block copolymer that exhibits excellent inhibitory effects against hydrate formation.

Career Highlights

Qihang Ding is affiliated with the Chinese Academy of Sciences, where he conducts his research and development activities. His work has been recognized for its innovative approach and practical applications in the field of hydrate inhibition.

Collaborations

Qihang Ding has collaborated with esteemed colleagues such as Zhen Long and Deqing Liang. These partnerships have contributed to the advancement of research in kinetic hydrate inhibitors and related fields.

Conclusion

Qihang Ding's contributions to the development of kinetic hydrate inhibitors highlight his role as a leading inventor in polymer chemistry. His innovative patent and collaborative efforts continue to influence the industry positively.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…